Prescription Politics and Educational Autonomy

This chapter explores a recent executive order aimed at reducing drug prices for Americans through enhanced Medicare negotiation powers. It also addresses the contentious relationship between the Trump administration and Harvard University over federal funding and tax-exempt status, highlighting legal challenges and broader implications for higher education. Experts discuss the political significance of drug pricing and institutional autonomy, emphasizing their impact on voters and ongoing debates about governance in academia.